DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

LinksSchließen

Referenz

Eikelboom JW, Wallentin L, Connolly SJ. et al.
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Circulation 2011;
123: 2363-2372.

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: